SUMMARY Thirty-two (64%) of 50 patients with motor neuron disease showed various patterns of cerebral atrophy (cortical, ventricular or both) at CT examination. The incidence of cerebral atrophy, particularly cortical atrophy, in motor neuron disease was greater than in a matched control group.
Involvement of the cerebral cortex in motor neuron disease was first described by Pierre Marie in 1883 and then was recognised by a number of authors. 1-3 Pathological changes were described mainly in motor, premotor and opercular regions, consisting of a reduction in number and degeneration of giant pyramidal cells of Betz.4 A reduction in the weight of the cerebral hemispheres with frontal lobe atrophy,5 and extensive degeneration involving several cortical regions and cerebral structures such as the thalamus, corpus striatum, subthalamic nucleus and substantia nigra have also been reported.67 More recently, the similarity between the type of neuronal degeneration in motor neuron disease and that seen in normal aging has been pointed out.8 9 Computed tomography (CT) has now provided the opportunity to investigate this disorder by a noninvasive and safe method. Considerable efforts have been made to correlate the findings of cortical and/or ventricular atrophy to age-related changes in normal populations,'0 " and to early disturbances of cognitive functions both in normal people'2 and in demented patients. '1'5 Brain atrophy revealed by CT has been also investigated in various neurological conditions such as Parkinson's disease '6 and hereditary ataxias. '7 In the present report we have studied the presence of cerebral atrophy at CT examination in motor neuron disease patients and its possible relationship with the clinical variables of the disease. 
Results
In the group of motor neuron disease patients, 36% had a normal score (CAS). 64% showed different patterns of cerebral atrophy: cortical (30%) or global (34%). In the control group, 54% were normal and 4%, 34% and 8% respectively displayed signs of cortical atrophy, ventricular enlargement or both. Poloni, Mascherpa, Faggi, Rognone, Gozzoli involvement in the first three motor neuron disease subtypes. Ventricular enlargement, on the other hand, did not appear to follow a similar distribution.
Discussion
The frequency of atrophic changes in the cortex of motor neuron disease patients was higher than in a control group both in objective and subjective measurements. If comparison is made between these CT results and previous reports on necropsy cases,57 64% exhibited cortical atrophy and 34% ventricular enlargement on CT, as compared to 50% of the Lawyer5 necropsy series, and one-third of cases in the Bromwell7 necropsy series.
In the group of volunteers over the age of 60 years investigated by Jacoby," the mean cortical atrophy score, calculated with the same criteria employed here, was 2 0 + 1-79 (1-5 in the seventh decade; 2 0 in the eighth decade and 3-2 in the ninth decade). The group studied here was considerably younger than this, but the mean score was clearly higher (4-6 ± 6-45) and significantly different from that of controls of matched age (184 ± 4-13). Ventricular dimensions were almost the same in motor neuron disease and control groups.
The regions with a high frequency of atrophic changes (frontai, parietal, insulae) are those of the sensori-motor cortex but, as already observed in pathological studies,57 cortical atrophy in motor neuron disease may be diffuse. This distribution does not seem to be different from that observed in other diseases of the central nervous system such as Parkinsonism 1 or in the subjects chosen as controls.
Cortical atrophy was not correlated with age either in motor neuron disease or in control group. A positive relation between cortical atrophy and age has been found in elderly "normal" people " I and in Parkinsonian patients, '6 but not in senile dementia patients.'9 A correlation was found for ventricular size and age in both groups. Ventricular atrophy tends to correlate better than cortical atrophy with age also in necropsy cases.20 These facts suggest a preferential relationship between cortical atrophy and disease. Ventricular atrophy, on the contrary, may be a collateral phenomenon determined by the physiologic processes of aging.
The frequency of appearance of cortical atrophy was higher in males than in females in motor neuron disease. This is not easy to explain, but there have been frequent reports of a preponderance of male to female patients with motor neuron disease2 ' 22 and the average age at onset is generally higher in females than in males. 22 Cortical 
